Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn Ioannis Koutsavlis Review Article 03 October 2020 Pages: 1 - 10
Is there a gender effect in polycythemia vera? Francesca PalandriBarbara MoraLucia Catani Review Article Open access 02 October 2020 Pages: 11 - 25
An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia Sylvie StacySujit ShethWendy Cerenzia Original Article Open access 01 September 2020 Pages: 27 - 35
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection Abdulrahman A. AlgassimAssem A. ElghazalyMahmoud D. Aljurf Original Article 12 September 2020 Pages: 37 - 43
Characteristics of coagulation alteration in patients with COVID-19 Hong-chun LuoCheng-yan YouYue-qiang Fu Original Article 20 October 2020 Pages: 45 - 52
Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine Yang LanLixian ChangXiaofan Zhu Original Article 08 October 2020 Pages: 53 - 61
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia Filipe MartinsMichael KruszewskiSabine Blum Original Article 16 June 2020 Pages: 63 - 78
Antibiotic use during cytarabine consolidation in acute myeloid leukemia Colin A. ValePamela C. EganJohn L. Reagan Original Article 01 September 2020 Pages: 79 - 84
Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India Abhijit PhukanPrakas Kumar MandalTuphan K. Dolai Original Article 06 October 2020 Pages: 85 - 96
Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm David C. A. MolitorPeter BoorInes Gütgemann Original Article Open access 26 October 2020 Pages: 97 - 104
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis Benedetta RambaldiElisa DiralMarta Serafini Original Article 21 October 2020 Pages: 105 - 116
Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019 Konnie HebedaLudmila BoudovaAlexandar Tzankov Original Article 31 October 2020 Pages: 117 - 133
Low-dose ruxolitinib shows effective in treating myelofibrosis Yunfan YangHongmei LuoLing Pan Original Article 20 October 2020 Pages: 135 - 141
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes William J. ArchibaldKari G. RabeSameer A. Parikh Original Article 01 June 2020 Pages: 143 - 155
Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry Shigeo FujiShuhei KidaJun Ishikawa Original Article 21 October 2020 Pages: 157 - 165
Correction to: Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry Shigeo FujiShuhei KidaJun Ishikawa Correction 28 November 2020 Pages: 167 - 167
Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide Jiao-Yu ZhaoSi-Ning LiuXiao-Dong Mo Original Article 07 November 2020 Pages: 169 - 180
Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors Catharina Van ElssenGwendolyn van GorkomGerard Bos Original Article Open access 28 October 2020 Pages: 181 - 187
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas Jae-Cheol JoJin-Seok KimWon-Sik Lee Original Article 17 November 2020 Pages: 189 - 196
Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study Yasuo MoriKensuke SasakiFukuoka Blood and Marrow Transplantation Group Original Article 05 November 2020 Pages: 197 - 208
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial Claire SeydouxMichael MedingerNathan Cantoni Original Article Open access 23 October 2020 Pages: 209 - 216
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia Yasushi OnishiTakehiko Morion behalf of the Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation Original Article 09 October 2020 Pages: 217 - 228
Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study Andry Van de LouwKathleen TwomeyKevin Rakszawski Original Article 12 September 2020 Pages: 229 - 237
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Boris BöllEnrico SchalkMarcus Hentrich Original Article Open access 30 September 2020 Pages: 239 - 259
Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study Loes L. CornelissenAukje L. KreugerJohanna G. van der Bom Original Article Open access 17 October 2020 Pages: 261 - 271
An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium Qiaoyan HanLan TaoMiao Sun Letter to the Editor 13 February 2020 Pages: 273 - 275
Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation Annalen BleckmannSascha DierksGerald Wulf Letter to the Editor Open access 20 March 2020 Pages: 277 - 279
Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant Manu JamwalAnu AggarwalReena Das Letter to the Editor 27 March 2020 Pages: 281 - 283
Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma Camille DebordJessie BourcierSoraya Wuillème Letter to the Editor 19 March 2020 Pages: 285 - 287
Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment Lu ZhangWei ZhangDaobin Zhou Letter to the Editor 25 April 2020 Pages: 289 - 291
Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia Ozlem OzbagcivanSevgi AkarsuEmel Fetil Letter to the Editor 27 March 2020 Pages: 293 - 294
A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient Jiaying LiuLijing ShenTingyu Yin Letter to the Editor 08 April 2020 Pages: 295 - 296
Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma Martin KaiserMeral BeksaçMeletios A. Dimopoulos Correction 27 October 2020 Pages: 297 - 302
Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments Alessia BariRaffaella MarcheselliFondazione Italiana Linfomi (Onlus) Correction 21 November 2020 Pages: 303 - 304
Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia Ke WanYafei YinJianzhao Cheng Correction 16 October 2020 Pages: 305 - 305
Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China Jing RuanWei ZuoBing Han Correction 02 November 2020 Pages: 307 - 307